EconPapers    
Economics at your fingertips  
 

In vivo imaging of specific drug–target binding at subcellular resolution

J. M. Dubach, C. Vinegoni (), R. Mazitschek, P. Fumene Feruglio, L. A. Cameron and R. Weissleder
Additional contact information
J. M. Dubach: Center for System Biology, Massachusetts General Hospital and Harvard Medical School, Richard B. Simches Research Center
C. Vinegoni: Center for System Biology, Massachusetts General Hospital and Harvard Medical School, Richard B. Simches Research Center
R. Mazitschek: Center for System Biology, Massachusetts General Hospital and Harvard Medical School, Richard B. Simches Research Center
P. Fumene Feruglio: Center for System Biology, Massachusetts General Hospital and Harvard Medical School, Richard B. Simches Research Center
L. A. Cameron: Dana-Farber Cancer Institute, 450 Brookline Ave.
R. Weissleder: Center for System Biology, Massachusetts General Hospital and Harvard Medical School, Richard B. Simches Research Center

Nature Communications, 2014, vol. 5, issue 1, 1-9

Abstract: Abstract The possibility of measuring binding of small-molecule drugs to desired targets in live cells could provide a better understanding of drug action. However, current approaches mostly yield static data, require lysis or rely on indirect assays and thus often provide an incomplete understanding of drug action. Here, we present a multiphoton fluorescence anisotropy microscopy live cell imaging technique to measure and map drug–target interaction in real time at subcellular resolution. This approach is generally applicable using any fluorescently labelled drug and enables high-resolution spatial and temporal mapping of bound and unbound drug distribution. To illustrate our approach we measure intracellular target engagement of the chemotherapeutic Olaparib, a poly(ADP-ribose) polymerase inhibitor, in live cells and within a tumour in vivo. These results are the first generalizable approach to directly measure drug–target binding in vivo and present a promising tool to enhance understanding of drug activity.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms4946 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4946

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms4946

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4946